Alendronate Sodium
FDA Approved, EMA Approved
Contents
Description
Alendronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption and increases bone mineral density. It is used in the treatment of osteoporosis and has been utilized off-label in managing avascular necrosis to prevent further bone collapse. The drug binds to hydroxyapatite in bone and reduces bone turnover.
Indications & Therapeutic Use
osteoporosis, Paget's disease of bone, idiopathic avascular necrosis (off-label)
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Alendronate Sodium — GNH India
42 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Acide Alendronique Viatris
EU
Ácido Alendrónico Generis Phar
EU
Ácido Alendrónico Semanal Mylan
EU
Alendronat Bluefish
EU
Alendronat Teva
EU
Alendronate Sodium
10 mg/1tabletUSA
Alendronato Mylan Generics
EU
Alendronato Sun Pharma Italia Srl
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Alendronate Sodium
| Generic Name | Alendronate Sodium |
| Brands | 1 brand available |
| Active Ingredient | Alendronate Sodium |
| Drug Class | osteoporosis |
| Manufacturer | Merck & Co. |
| Dosage Forms | Oral tablet, 5mg, 10mg, 35mg, 70mg |
| Medical Code | M05BA04 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved, EMA Approved |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes